Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling

Sclerosteosis is a rare high bone mass disease that is caused by inactivating mutations in the SOST gene. Its gene product, Sclerostin, is a key negative regulator of bone formation and might therefore serve as a target for the anabolic treatment of osteoporosis. The exact molecular mechanism by whi...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dinther, Maarten, Zhang, Juan, Weidauer, Stella E., Boschert, Verena, Muth, Eva-Maria, Knappik, Achim, de Gorter, David J. J., van Kasteren, Puck B., Frisch, Christian, Mueller, Thomas D., ten Dijke, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639248/
https://www.ncbi.nlm.nih.gov/pubmed/23638027
http://dx.doi.org/10.1371/journal.pone.0062295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639248/
https://www.ncbi.nlm.nih.gov/pubmed/23638027
http://dx.doi.org/10.1371/journal.pone.0062295

Ejemplares similares